Overview

Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.

Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
A Multicenter, acute, randomized, double-blind, placebo-controlled, flexible-dose trial with the treatment of sertraline.
Phase:
Phase 4
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Treatments:
Sertraline